Eli Lilly cuts list price, out-of-pocket costs for some of its insulins

Mar 2, 2023
The drug maker announced it's cutting the price of its most commonly-used insulins by 70%, and capping patients' out-of-pocket cost at $35 at certain participating pharmacies.
Pharmaceutical giant Eli Lilly announced Wednesday that it would cap the price for some of its insulin at $35 at certain pharmacies.
NIKLAS HALLE'N/AFP via Getty Images

Health professionals wonder about future of COVID drugs as federal funding wanes

Jun 29, 2022
Drugmaker Eli Lilly will supply the government with another 150,000 doses of its monoclonal antibody to meet short-term demand.
A free monoclonal antibody treatment site in Miami. Eli Lilly said it will provide more of its antibody medication to the government, but drugmakers may shift their sales to the commercial market.
Joe Raedle/Getty Images

Here's why Eli Lilly will sell a generic insulin

Mar 4, 2019
Lawmakers have been critical of big pharma's pricing structures.

Looking for progress for treating Alzheimer's

Jul 22, 2015
Eli Lilly reports the results of a trial for Alzheimer's medication.

What Eli Lilly's job cuts mean for the future of sales jobs

Apr 12, 2013
Eli Lilly is reducing its U.S. sales force, reportedly by 30 percent. How have digital and other advertising practices changed the nature of sales?